Stellanova_Logo.png
Stellanova Therapeutics, Inc. Announces Closing of $15.5 Million Series A Financing
June 03, 2021 08:00 ET | Stellanova Theraputic
HOUSTON, June 03, 2021 (GLOBE NEWSWIRE) -- Stellanova Therapeutics, Inc. (“Stellanova”), a biotechnology company advancing cancer therapies targeting the tumor microenvironment, today announced the...